Pulmonx Corporation Net Profit Margin 2019-2024 | LUNG
Pulmonx Corporation net profit margin from 2019 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Pulmonx Corporation Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-09-30 | $0.08B | $-0.06B | -72.15% |
| 2024-06-30 | $0.08B | $-0.06B | -75.32% |
| 2024-03-31 | $0.07B | $-0.06B | -80.82% |
| 2023-12-31 | $0.07B | $-0.06B | -88.41% |
| 2023-09-30 | $0.07B | $-0.06B | -93.85% |
| 2023-06-30 | $0.06B | $-0.06B | -98.36% |
| 2023-03-31 | $0.06B | $-0.06B | -101.72% |
| 2022-12-31 | $0.05B | $-0.06B | -109.26% |
| 2022-09-30 | $0.05B | $-0.06B | -109.43% |
| 2022-06-30 | $0.05B | $-0.05B | -103.85% |
| 2022-03-31 | $0.05B | $-0.05B | -104.00% |
| 2021-12-31 | $0.05B | $-0.05B | -102.08% |
| 2021-09-30 | $0.04B | $-0.05B | -102.27% |
| 2021-06-30 | $0.04B | $-0.04B | -92.86% |
| 2021-03-31 | $0.03B | $-0.04B | -111.76% |
| 2020-12-31 | $0.03B | $-0.03B | -94.12% |
| 2020-06-30 | $0.02B | $-0.02B | -104.55% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.354B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||